Johnson & Johnson (JNJ) has a consensus analyst rating of Buy, based on 40 analysts covering the stock. Of those, 20 recommend buying, 17 recommend holding, and 3 recommend selling.
The analyst consensus price target for JNJ is $228.73, representing a -4.7% downside from the current price of $240.1. Price targets range from a low of $190.00 to a high of $265.00.
